stage iii urethral cancer ajcc v8
Showing 1 - 7 of 7
Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Locally Advanced Bladder Carcinoma
Recruiting
- Clinical Stage III Cutaneous Melanoma AJCC v8
- +41 more
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 11, 2022
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Not yet recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +31 more
- Diagnostic Laboratory Biomarker Analysis
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Advanced Bladder Urothelial Carcinoma, Advanced Renal Pelvis Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma Trial in
Recruiting
- Advanced Bladder Urothelial Carcinoma
- +17 more
- Avelumab
- +3 more
-
Auburn, California
- +111 more
Aug 17, 2022
Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in
Recruiting
- Advanced Bladder Urothelial Carcinoma
- +23 more
- Atezolizumab
- +2 more
-
Riverside, California
- +8 more
Jul 16, 2022
Bladder Small Cell Neuroendocrine Carcinoma, Castration-Resistant Prostate Carcinoma, Metastatic Bladder Urothelial Carcinoma
Recruiting
- Bladder Small Cell Neuroendocrine Carcinoma
- +16 more
- Carboplatin
- +4 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Mar 23, 2022
Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall, Stage II Bladder Cancer AJCC v8, Stage II Renal Pelvis Cancer
Completed
- Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall
- +11 more
- Avelumab
- +5 more
-
Scottsdale, Arizona
- +2 more
Mar 12, 2021
Recurrent Bladder Urothelial Carcinoma, Recurrent Renal Pelvis Urothelial Carcinoma, Recurrent Ureter Urothelial Carcinoma Trial
Completed
- Recurrent Bladder Urothelial Carcinoma
- +19 more
- Erlotinib Hydrochloride
-
Houston, TexasM D Anderson Cancer Center
Aug 21, 2020